semaglutide fda warning The U.S. Food and Drug Administration (FDA) has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications FDA Clears Semaglutide For Cardiac

Contact your healthcare provider if you experience persistent vomiting for more than 24 hours, severe abdominal pain, signs of dehydration, or if nausea significantly impacts your quality of life

And if anything you might be exposed to more update and current information, but then at the same time, there's so many influencers and there's until much of it is just trendy and click bait and you know, short attention span and not giving you a lot of information that you need

Monitoring Your Progress Regular monitoring helps ensure youre getting the most benefit safely

Red flag symptomsincluding severe abdominal pain, rectal bleeding, unintentional weight loss, or a significant change in bowel habitrequire prompt medical assessment to exclude serious underlying pathology